In a regulatory filing, Humana stated, “The company is currently assessing the expected impact of emerging utilization trends on its 2024 outlook, which is anticipated to be material if current trends continue, and will provide an update on its fourth quarter 2023 earnings call. Importantly, Humana believes the emerging trends are impacting the industry broadly and anticipates the trends will be contemplated in the 2025 Medicare Advantage pricing cycle.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HUM:
- Boeing, Humana removed from ‘US 1 list’ at BofA
- Walgreens agrees to pay $360M to Humana to settle pricing dispute, WSJ reports
- Humana named 2024 Top Pick at Argus
- M & A News: Cigna (NYSE:CI) Explores Medicare Business Sale
- TipRanks’ ‘Perfect 10’ List: These 3 Top-Scoring Stocks Are Poised to Outperform in 2024